391 related articles for article (PubMed ID: 18227853)
1. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
Lee H; Whitfeld PL; Mackay CR
Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
[TBL] [Abstract][Full Text] [Related]
2. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
[TBL] [Abstract][Full Text] [Related]
3. Disruption of the complement anaphylatoxin receptor C5L2 exacerbates inflammation in allergic contact dermatitis.
Wang R; Lu B; Gerard C; Gerard NP
J Immunol; 2013 Oct; 191(8):4001-9. PubMed ID: 24043888
[TBL] [Abstract][Full Text] [Related]
4. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
[TBL] [Abstract][Full Text] [Related]
5. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
[TBL] [Abstract][Full Text] [Related]
6. The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation.
Bosmann M; Haggadone MD; Zetoune FS; Sarma JV; Ward PA
Eur J Immunol; 2013 Jul; 43(7):1907-13. PubMed ID: 23575697
[TBL] [Abstract][Full Text] [Related]
7. TLR activation enhances C5a-induced pro-inflammatory responses by negatively modulating the second C5a receptor, C5L2.
Raby AC; Holst B; Davies J; Colmont C; Laumonnier Y; Coles B; Shah S; Hall J; Topley N; Köhl J; Morgan BP; Labéta MO
Eur J Immunol; 2011 Sep; 41(9):2741-52. PubMed ID: 21630250
[TBL] [Abstract][Full Text] [Related]
8. The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction.
Bamberg CE; Mackay CR; Lee H; Zahra D; Jackson J; Lim YS; Whitfeld PL; Craig S; Corsini E; Lu B; Gerard C; Gerard NP
J Biol Chem; 2010 Mar; 285(10):7633-44. PubMed ID: 20044484
[TBL] [Abstract][Full Text] [Related]
9. Treatment with anti-C5aR mAb leads to early-onset clinical and mechanistic effects in the murine delayed-type hypersensitivity arthritis model.
Atkinson SM; Nansen A; Usher PA; Sondergaard BC; Mackay CR; Friedrichsen B; Chang CC; Tang R; Skov S; Haase C; Hornum L
Autoimmunity; 2015; 48(7):460-70. PubMed ID: 25915570
[TBL] [Abstract][Full Text] [Related]
10. Functions of C5a receptors.
Ward PA
J Mol Med (Berl); 2009 Apr; 87(4):375-8. PubMed ID: 19189071
[TBL] [Abstract][Full Text] [Related]
11. C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology.
Poursharifi P; Lapointe M; Pétrin D; Devost D; Gauvreau D; Hébert TE; Cianflone K
Cell Signal; 2013 Apr; 25(4):910-8. PubMed ID: 23268185
[TBL] [Abstract][Full Text] [Related]
12. A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation.
Hao J; Wang C; Yuan J; Chen M; Zhao MH
PLoS One; 2013; 8(6):e66305. PubMed ID: 23785491
[TBL] [Abstract][Full Text] [Related]
13. C5aR and C5L2 act in concert to balance immunometabolism in adipose tissue.
Poursharifi P; Lapointe M; Fisette A; Lu H; Roy C; Munkonda MN; Fairlie DP; Cianflone K
Mol Cell Endocrinol; 2014 Jan; 382(1):325-333. PubMed ID: 24397921
[TBL] [Abstract][Full Text] [Related]
14. Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria.
Kim H; Erdman LK; Lu Z; Serghides L; Zhong K; Dhabangi A; Musoke C; Gerard C; Cserti-Gazdewich C; Liles WC; Kain KC
Infect Immun; 2014 Jan; 82(1):371-9. PubMed ID: 24191300
[TBL] [Abstract][Full Text] [Related]
15. Complement 5a receptor-mediated neutrophil dysfunction is associated with a poor outcome in sepsis.
Xu R; Lin F; Bao C; Huang H; Ji C; Wang S; Jin L; Sun L; Li K; Zhang Z; Wang FS
Cell Mol Immunol; 2016 Jan; 13(1):103-9. PubMed ID: 25726869
[TBL] [Abstract][Full Text] [Related]
16. Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies.
Lee H; Zahra D; Vogelzang A; Newton R; Thatcher J; Quan A; So T; Zwirner J; Koentgen F; Padkjaer SB; Mackay F; Whitfeld PL; Mackay CR
Nat Biotechnol; 2006 Oct; 24(10):1279-84. PubMed ID: 16980974
[TBL] [Abstract][Full Text] [Related]
17. C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid.
Hornum L; Hansen AJ; Tornehave D; Fjording MS; Colmenero P; Wätjen IF; Søe Nielsen NH; Bliddal H; Bartels EM
PLoS One; 2017; 12(12):e0189017. PubMed ID: 29220376
[TBL] [Abstract][Full Text] [Related]
18. Allosterism in human complement component 5a ((h)C5a): a damper of C5a receptor (C5aR) signaling.
Rana S; Sahoo AR; Majhi BK
J Biomol Struct Dyn; 2016 Jun; 34(6):1201-13. PubMed ID: 26212097
[TBL] [Abstract][Full Text] [Related]
19. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
[TBL] [Abstract][Full Text] [Related]
20. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
Strainic MG; Shevach EM; An F; Lin F; Medof ME
Nat Immunol; 2013 Feb; 14(2):162-71. PubMed ID: 23263555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
